We use cookies and other tools to enhance your experience on our website and to analyze our web traffic.
For more information about these cookies and the data collected, please refer to our
Privacy Policy.
pct_epoch_1to1_25pct
under
Sleep Monitoring/Polysomnography/Electroencephalogram
in
SHHS variables
Distribution of 30-s epochs, as a percent of total recording time in different Odds Ratio Product (ORP) deciles. Younes et al. 2022 (PubMed ID: 35272350) ORP is a continuous index of sleep depth and wake propensity. A value of 0 indicates very deep sleep; a value of 2.5 indicates full wakefulness. These values are used to construct the ORP histogram and ORP phenotype (:orp_type:). Search for all EEG variables within this dataset
pct_epoch_2_25to2_5pct
under
Sleep Monitoring/Polysomnography/Electroencephalogram
in
SHHS variables
Distribution of 30-s epochs, as a percent of total recording time in different Odds Ratio Product (ORP) deciles. Younes et al. 2022 (PubMed ID: 35272350) ORP is a continuous index of sleep depth and wake propensity. A value of 0 indicates very deep sleep; a value of 2.5 indicates full wakefulness. These values are used to construct the ORP histogram and ORP phenotype (:orp_type:). Search for all EEG variables within this dataset
pct_epoch_2to2_25pct
under
Sleep Monitoring/Polysomnography/Electroencephalogram
in
SHHS variables
Distribution of 30-s epochs, as a percent of total recording time in different Odds Ratio Product (ORP) deciles. Younes et al. 2022 (PubMed ID: 35272350) ORP is a continuous index of sleep depth and wake propensity. A value of 0 indicates very deep sleep; a value of 2.5 indicates full wakefulness. These values are used to construct the ORP histogram and ORP phenotype (:orp_type:). Search for all EEG variables within this dataset
warf1
under
Medical History/Medications/SHHS1
in
SHHS variables
Participant taking ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
hprns2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking HEPARINS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
warf2
under
Medical History/Medications/SHHS2
in
SHHS variables
Participant taking ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
ms204a
under
Sleep Monitoring/Polysomnography/Evening and Morning Survey/SHHS2
in
SHHS variables
Rate the actual quality of your sleep last night (Do not compare to usual sleep quality). My sleep last night was (circle a number for each): a. [5 point Likert scale from "Light" to "Dark"]